tiprankstipranks
Trending News
More News >
Aptose Biosciences (APTOF)
OTHER OTC:APTOF
US Market

Aptose Biosciences (APTOF) Stock Forecast & Price Target

Compare
1,274 Followers
See the Price Targets and Ratings of:

APTOF Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Aptose
Biosciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

APTOF Stock 12 Month Forecast

There Are No Analyst Ratings for APTOF In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

APTOF Financial Forecast

APTOF Earnings Forecast

The previous quarter’s earnings for APTOF were -$2.01.
The previous quarter’s earnings for APTOF were -$2.01.
No data currently available

APTOF Sales Forecast

The previous quarter’s earnings for APTOF were $0.00.
The previous quarter’s earnings for APTOF were $0.00.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Alliance Global Partners Analyst forecast on APTOF
Alliance Global Partners
Alliance Global Partners
$1.78
Hold
13.83%
Upside
Downgraded
11/24/25
Aptose Biosciences downgraded to Neutral from Buy at Alliance GlobalAptose Biosciences downgraded to Neutral from Buy at Alliance Global
H.C. Wainwright Analyst forecast on APTOF
H.C. Wainwright
H.C. Wainwright
$2$6
Buy
284.62%
Upside
Reiterated
03/31/25
Aptose Biosciences (APTO) PT Raised to $6 at H.C. WainwrightH.C. Wainwright analyst Joseph Pantginis raised the price target on Aptose Biosciences (NASDAQ: APTO) to $6.00 (from $2.00) while maintaining a Buy rating.
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Alliance Global Partners Analyst forecast on APTOF
Alliance Global Partners
Alliance Global Partners
$1.78
Hold
13.83%
Upside
Downgraded
11/24/25
Aptose Biosciences downgraded to Neutral from Buy at Alliance GlobalAptose Biosciences downgraded to Neutral from Buy at Alliance Global
H.C. Wainwright Analyst forecast on APTOF
H.C. Wainwright
H.C. Wainwright
$2$6
Buy
284.62%
Upside
Reiterated
03/31/25
Aptose Biosciences (APTO) PT Raised to $6 at H.C. WainwrightH.C. Wainwright analyst Joseph Pantginis raised the price target on Aptose Biosciences (NASDAQ: APTO) to $6.00 (from $2.00) while maintaining a Buy rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Aptose Biosciences

3 Months
xxx
Success Rate
0/5 ratings generated profit
0%
Average Return
-58.92%
reiterated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -58.92% per trade.
1 Year
Joseph PantginisH.C. Wainwright
Success Rate
0/5 ratings generated profit
0%
Average Return
-70.48%
reiterated a buy rating 12 months ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -70.48% per trade.
2 Years
xxx
Success Rate
0/5 ratings generated profit
0%
Average Return
-71.46%
reiterated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -71.46% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

APTOF Analyst Recommendation Trends

Rating
Apr 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
4
2
0
0
0
Buy
0
0
0
0
0
Hold
0
1
2
16
18
Sell
3
3
3
1
1
Strong Sell
0
0
0
0
0
total
7
6
5
17
19
In the current month, APTOF has received 0 Buy Ratings, 18 Hold Ratings, and 1 Sell Ratings. APTOF average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

APTOF Stock Forecast FAQ

What is APTOF’s average 12-month price target, according to analysts?
Currently, no data Available
What is APTOF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for APTOF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is APTOF a Buy, Sell or Hold?
      Currently, no data Available
      What is Aptose Biosciences’s price target?
      Currently, no data Available
      What do analysts say about Aptose Biosciences?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of APTOF?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.